Lorlatinib 100mg Tablets in India ALK

So, Lorlatinib is this really cool new kind of drug that’s designed to target those ALK and ROS1 things. It’s mainly for people with that tricky lung cancer thing, the NSCLC, that’s ALK-positive and doesn’t respond to other ALK drugs. The drug goes after these ALK and ROS1 kinases to try and stop the cancer cells from growing.

You can get it in two doses, 25 mg or 100 mg. The usual dose for adults is 100 mg, you can take it with or without food, just once a day. It comes in bottles with 30 tablets inside.

It works by blocking those ALK and ROS1 mutations that are like the main cause of the cancer cells growing in some NSCLC patients.